2023. Treatment or Psoriasis with Calcipotriene and Betamethasone Dipropionate (CAL/BDP) Cream Showed Significantly Higher Proportion of Patients with an Absolute mPASI≤2 Compared to CAL/BDP Gel/Topical Suspension in a Post-Hoc Aanalysis of Two Phase 3 Studies. SKIN The Journal of Cutaneous Medicine. 7, 6 (Nov. 2023), s233. DOI:https://doi.org/10.25251/skin.7.supp.233.